Sex- and Gender-Related Aspects in Pulmonary Hypertension

被引:3
作者
D'Agostino, Anna [1 ]
Guindani, Paola [2 ]
Scaglione, Gerarda [2 ]
Di Vincenzo, Alessandra [2 ]
Tamascelli, Sara [2 ]
Spaggiari, Riccardo [2 ]
Salzano, Andrea [1 ]
D'Amuri, Andrea [2 ]
Marra, Alberto Maria [3 ,4 ]
Pilote, Louise [5 ]
Raparelli, Valeria [2 ,6 ,7 ,8 ,9 ]
机构
[1] IRCCS SYNLAB SDN, Naples, Italy
[2] Univ Internal Med Unit, Univ Hosp St Anna, Dept Med, Ferrara, Italy
[3] Federico II Univ Naples, Dept Translat Med Sci, Naples, Italy
[4] Federico II Univ Naples, Interdept Ctr Biomat CRIB, Naples, Italy
[5] McGill Univ Hlth Ctr Res Inst, Div Clin Epidemiol & Gen Internal Med, Montreal, PQ, Canada
[6] Univ Ferrara, Dept Translat Med, Ferrara, Italy
[7] Univ Ferrara, Univ Ctr Studies Gender Med, Ferrara, Italy
[8] Univ Alberta, Fac Nursing, Edmonton, AB, Canada
[9] Univ Ferrara, Dept Translat Med, Via Borsari 46, I-44121 Ferrara, Italy
关键词
Sex; Gender identity; Socioeconomic status; Pulmonary hypertension; Outcomes; Marital status; Employment; Epidemiology; RIGHT-HEART-FAILURE; QUALITY-OF-LIFE; ARTERIAL-HYPERTENSION; SOCIOECONOMIC-STATUS; ENDOGENOUS ESTROGEN; RIGHT VENTRICLE; SURVIVAL; DISEASE; HEALTH; DEPRESSION;
D O I
10.1016/j.hfc.2022.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Females are more affected by PAH compared with males. Despite female patients with PAH having a higher WHO functional class, male PAH patients have a more impaired RV function and hemody-namics compared with females with PAH. For this reason, males affected by PAH have poorer outcomes than females. The effects of estrogens and other sex hormones on the pulmonary vascu-lature and RV are complex yet highly fascinating because of their direct relevance to clinical mani-festations of various forms of PAH. Beyond sex (biological-based) differences, the interplay between gender domains and PAH has been only partially studied. PAH has a significant impact on daily lives of patients and caregivers. It generates changes in many social roles such as at work (eg, reduction in the job efficiency) and within the family (limited activities as parent or partner). Social isolation affects the QOL of both PAH patients and their careers, resulting in the loss of social roles that patients once held. As patients with PH feel like having an "invisible" disease, lacking the understanding by patients' social network, psychological support should be offered according to guidelines. In fact, emotional support can help to improve the outcome of PAH. Finally, differences in society and opportunities can relate with gender identity, in particular for individuals that are often discriminated such as transgender people. Lower SES and incomes are associated with different etiologies, a delay in diagnosis and treatment, a more severe disease at first visit, and therefore a raise in mortality and a worse prognosis. Even the educational level might play an important role, despite not being still clearly investigated in the literature. Further studies, aimed at understanding the mechanisms behind the observed sex-and gender-based differences in PAH, may inform the development of novel tailored and personal-ized approaches for the management of PAH patients.
引用
收藏
页码:11 / 24
页数:14
相关论文
共 105 条
  • [1] Interleukin-6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men
    Akinyemi, Rufus
    Arnett, Donna K.
    Tiwari, Hemant K.
    Ovbiagele, Bruce
    Sarfo, Fred
    Srinivasasainagendra, Vinodh
    Irvin, Marguerite Ryan
    Adeoye, Abiodun
    Perry, Rodney T.
    Akpalu, Albert
    Jenkins, Carolyn
    Owolabi, Lukman
    Obiako, Reginald
    Wahab, Kolawole
    Sanya, Emmanuel
    Komolafe, Morenikeji
    Fawale, Michael
    Adebayo, Philip
    Osaigbovo, Godwin
    Sunmonu, Taofiki
    Olowoyo, Paul
    Chukwuonye, Innocent
    Obiabo, Yahaya
    Akpa, Onoja
    Melikam, Sylvia
    Saulson, Raelle
    Kalaria, Raj
    Ogunniyi, Adesola
    Owolabi, Mayowa
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 379 : 229 - 235
  • [2] The trajectory to diagnosis with pulmonary arterial hypertension: a qualitative study
    Armstrong, Ian
    Rochnia, Nikki
    Harries, Carl
    Bundock, Sarah
    Yorke, Janelle
    [J]. BMJ OPEN, 2012, 2 (02):
  • [3] Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females
    Austin, E. D.
    Cogan, J. D.
    West, J. D.
    Hedges, L. K.
    Hamid, R.
    Dawson, E. P.
    Wheeler, L. A.
    Parl, F. F.
    Loyd, J. E.
    Phillips, J. A., III
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (05) : 1093 - 1099
  • [4] Health Literacy and Health Outcomes in Chronic Obstructive Pulmonary Disease Patients: An Explorative Study
    Azkan Ture, Deniz
    Bhattacharya, Sudip
    Demirci, Hakan
    Yildiz, Tekin
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [5] SANRA-a scale for the quality assessment of narrative review articles
    Baethge, Christopher
    Goldbeck-Wood, Sandra
    Mertens, Stephan
    [J]. RESEARCH INTEGRITY AND PEER REVIEW, 2019, 4 (01)
  • [6] Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension
    Baird, Grayson L.
    Archer-Chicko, Christine
    Barr, R. Graham
    Bluemke, David A.
    Foderaro, Andrew E.
    Fritz, Jason S.
    Hill, Nicholas S.
    Kawut, Steven M.
    Klinger, James R.
    Lima, Joao A. C.
    Mullin, Christopher J.
    Ouyang, Pamela
    Palevsky, Harold, I
    Palmisicano, Amy J.
    Pinder, Diane
    Preston, Ioana R.
    Roberts, Kari E.
    Smith, K. Akaya
    Walsh, Thomas
    Whittenhall, Mary
    Ventetuolo, Corey E.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (06)
  • [7] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
    Barst, RJ
    Rubin, LJ
    Long, WA
    McGoon, MD
    Rich, S
    Badesch, DB
    Groves, BM
    Tapson, VF
    Bourge, RC
    Brundage, BH
    Koerner, SK
    Langleben, D
    Keller, CA
    Murali, S
    Uretsky, BF
    Clayton, LM
    Jobsis, MM
    Blackburn, SD
    Shortino, D
    Crow, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) : 296 - 301
  • [8] Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease
    Batton, Kyle A.
    Austin, Christopher O.
    Bruno, Katelyn A.
    Burger, Charles D.
    Shapiro, Brian P.
    Fairweather, DeLisa
    [J]. BIOLOGY OF SEX DIFFERENCES, 2018, 9
  • [9] EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension
    Best, D. Hunter
    Sumner, Kelli L.
    Smith, Benjamin P.
    Damjanovich-Colmenares, Kristy
    Nakayama, Ikue
    Brown, Lynette M.
    Ha, Youna
    Paul, Eleri
    Morris, Ashley
    Jama, Mohamed A.
    Dodson, Mark W.
    Bayrak-Toydemir, Pinar
    Elliott, C. Gregory
    [J]. CHEST, 2017, 151 (04) : 821 - 828
  • [10] The Right Ventricle Under Pressure Cellular and Molecular Mechanisms of Right-Heart Failure in Pulmonary Hypertension
    Bogaard, Harm J.
    Abe, Kohtaro
    Noordegraaf, Anton Vonk
    Voelkel, Norbert F.
    [J]. CHEST, 2009, 135 (03) : 794 - 804